Thiol-Redox Signaling, Dopaminergic Cell Death, and Parkinson's Disease
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
SIGNIFICANCE: Parkinson's disease (PD) is characterized by the selective loss of dopaminergic neurons of the substantia nigra pars compacta, which has been widely associated with oxidative stress. However, the mechanisms by which redox signaling regulates cell death progression remain elusive. RECENT ADVANCES: Early studies demonstrated that depletion of glutathione (GSH), the most abundant low-molecular-weight thiol and major antioxidant defense in cells, is one of the earliest biochemical events associated with PD, prompting researchers to determine the role of oxidative stress in dopaminergic cell death. Since then, the concept of oxidative stress has evolved into redox signaling, and its complexity is highlighted by the discovery of a variety of thiol-based redox-dependent processes regulating not only oxidative damage, but also the activation of a myriad of signaling/enzymatic mechanisms. CRITICAL ISSUES: GSH and GSH-based antioxidant systems are important regulators of neurodegeneration associated with PD. In addition, thiol-based redox systems, such as peroxiredoxins, thioredoxins, metallothioneins, methionine sulfoxide reductases, transcription factors, as well as oxidative modifications in protein thiols (cysteines), including cysteine hydroxylation, glutathionylation, and nitrosylation, have been demonstrated to regulate dopaminergic cell loss. FUTURE DIRECTIONS: In this review, we summarize major advances in the understanding of the role of thiol-redox signaling in dopaminergic cell death in experimental PD. Future research is still required to clearly understand how integrated thiol-redox signaling regulates the activation of the cell death machinery, and the knowledge generated should open new avenues for the design of novel therapeutic approaches against PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
Thiol chemistry and specificity in redox signaling
Winterbourn, C. C., & Hampton, M. B. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.004 · Cited by 1,226
Klivenyi, P., Andreassen, O. A., Ferrante, R. J., Dedeoglu, A., Mueller, G., Lancelot, E., Bogdanov, M., Andersen, J. K., Jiang, D., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00001.2000 · Cited by 1,111 · cited 1×
“…re-ported to exert a protective effect against dopaminergic cell death, as mice deficient in glutathione peroxidase 1 (GPX1) exhibit an increased sensitivity to MPTP toxicity (98), while its overexpression protects against MPP + - and 6-OHDA-induced toxicity in vitro and in vivo (17, 88, 145, 169).”
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883
Expanding insights of mitochondrial dysfunction in Parkinson's disease
Abou-Sleiman, P. M., Muqit, M. M. K., & Wood, N. W. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1868 · Cited by 869 · cited 31×
“Mutant a -synuclein and environmental toxins impair vesicular dopamine transporter 2 (VMAT2) augmenting cytosolic dopamine levels, where dopamine is metabolized by monoamine oxidase (MAO) or auto-oxidized generating RS and dopamine-quinone species (DAQ) (3) .”
InfluentialAlam, Z. I., Jenner, A., Daniel, S. E., Lees, A. J., Cairns, N., Marsden, C. D., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031196.x · Cited by 845 · cited 7×
“Environmental toxins have been shown to induce oxidative damage through a variety of mechanisms, including impairment of mitochondrial electron transport chain (ETC) (1), auto-catalytic generation of RS (5), increased intracellular dopamine catabolism, activation of plasma membrane nicotinamide adenine dinucleotide ph…”
InfluentialClements, C. M., McNally, R. S., Conti, B. J., Mak, T. W., & Ting, J. P.-Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607260103 · Cited by 818 · cited 8×
“Oxidants or electrophiles induce a conformational change in Keap1 that allows the translocation of Nrf2 to the nucleus for transduction.”
InfluentialProtein S-nitrosylation in health and disease: a current perspective
Foster, M. W., Hess, D. T., & Stamler, J. S. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.06.007 · Cited by 752
Toxin-induced models of Parkinson’s disease
Bové, J., Prou, D., Perier, C., & Przedborski, S. (2005) · NeuroRX · doi:10.1602/neurorx.2.3.484 · Cited by 739 · cited 1×
“Accordingly, toxins, such as MPTP, rotenone, and paraquat, act primarily by inhibition of complex I, a major component of the ETC, leading to an increased generation of RS (20, 159).”
Snow, B. J., Rolfe, F. L., Lockhart, M. M., Frampton, C. M., O'Sullivan, J. D., Fung, V., Smith, R. A. J., Murphy, M. P., Taylor, K. M., & On behalf of the Protect Study Group (2010) · Movement Disorders · doi:10.1002/mds.23148 · Cited by 606
Chen, P.-C., Vargas, M. R., Pani, A. K., Smeyne, R. J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813361106 · Cited by 579
Choi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., Chin, L.-S., & Li, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314124200 · Cited by 568 · cited 2×
“MPP + Sulfinic/sulfonic acid DJ-1 Irreversible (4, 23) Parkin (120) Sulfonic acid Parkin Irreversible (120) S-nitrosylation Parkin Reversible (35, 192) PRDX2 Reversible (55) S-nitrosylation XIAP Reversible (172) Glutathionylation IDPM Reversible (97) Rotenone S-nitrosylation Parkin Reversible (192) PDI Reversible (173…”
Molecular Mechanisms and Clinical Implications of Reversible Protein S -Glutathionylation
Mieyal, J. J., Gallogly, M. M., Qanungo, S., Sabens, E. A., & Shelton, M. D. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2089 · Cited by 523
Farr, S. A., Poon, H. F., Dogrukol‐Ak, D., Drake, J., Banks, W. A., Eyerman, E., Butterfield, D. A., & Morley, J. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01580.x · Cited by 459 · cited 4×
“Studies have demonstrated that GSH is transported across the BBB in the rat and guinea pig, while human cerebrovascular endothelial cells exhibit GSH uptake and efflux (90, 91, 201).”
InfluentialAdam-Vizi, V. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1140 · Cited by 439
Beer, S. M., Taylor, E. R., Brown, S. E., Dahm, C. C., Costa, N. J., Runswick, M. J., & Murphy, M. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408011200 · Cited by 404
Behavioral and Neurochemical Effects of Wild-Type and Mutated Human α-Synuclein in Transgenic Mice
Richfield, E. K., Thiruchelvam, M. J., Cory-Slechta, D. A., Wuertzer, C., Gainetdinov, R. R., Caron, M. G., Di Monte, D. A., & Federoff, H. J. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7882 · Cited by 285 · cited 1×
“However, only marginal or null dopaminergic cell death has been observed in genetic-based animal models (144, 170), which suggests that genetic risk factors are not sufficient and that environmental exposures may also be required for nigral dopamine neuronal degeneration (gene– environment…”
The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s disease
Hastings, T. G. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9257-z · Cited by 199 · cited 7×
“Mutant a -synuclein and environmental toxins impair vesicular dopamine transporter 2 (VMAT2) augmenting cytosolic dopamine levels, where dopamine is metabolized by monoamine oxidase (MAO) or auto-oxidized generating RS and dopamine-quinone species (DAQ) (3) .”
InfluentialMetallothionein in the central nervous system: Roles in protection, regeneration and cognition
West, A. K., Hidalgo, J., Eddins, D., Levin, E. D., & Aschner, M. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2007.12.006 · Cited by 190 · cited 1×
“MTs usually bind 7 divalent metal ions (Zn(2) + ) and up to 12 monovalent Cu + ions, partitioned into 12 metal-thiolate clusters located in separate protein domains (182).”
Chinta, S. J., Kumar, M. J., Hsu, M., Rajagopalan, S., Kaur, D., Rane, A., Nicholls, D. G., Choi, J., & Andersen, J. K. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3885-07.2007 · Cited by 145 · cited 1×
“GSH depletion inhibits mitochondrial complex I activity in vitro and in vivo (28, 47, 86), and this has been associated with cysteine post-translational modifications (29, 47).”
Randomized, double‐blind, pilot evaluation of intravenous glutathione in Parkinson's disease
Hauser, R. A., Lyons, K. E., McClain, T., Carter, S., & Perlmutter, D. (2009) · Movement Disorders · doi:10.1002/mds.22401 · Cited by 143 · cited 1×
“A recent randomized clinical trial failed to demonstrate a protective effect of intravenous GSH administration in PD patients (74).”
Striatal Neuroinflammation Promotes Parkinsonism in Rats
Choi, D.-Y., Liu, M., Hunter, R. L., Cass, W. A., Pandya, J. D., Sullivan, P. G., Shin, E.-J., Kim, H.-C., Gash, D. M., & Bing, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005482 · Cited by 141 · cited 1×
“Progressive dopaminergic degeneration by LPS-induced neuroinflammation was recently shown to be preceded by PSNO of mitochondrial complex I, which was prevented by NOS inhibitors (31).”
Saini, N., Georgiev, O., & Schaffner, W. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05207-11 · Cited by 49 · cited 1×
“Double-mutant flies for Parkin and MTF-1 genes are not viable, while over-expression of MTF-1 of Drosophila MT dramatically augments life span and protects mitochondrial structure (155).”
Cited by
Bogetofte, H., Jensen, P., Okarmus, J., Schmidt, S. I., Agger, M., Ryding, M., Nørregaard, P., Fenger, C., Zeng, X., Graakjær, J., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104581 · Cited by 35
Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice
Verma, A., Ray, A., Bapat, D., Diwakar, L., Kommaddi, R. P., Schneider, B. L., Hirsch, E. C., & Ravindranath, V. (2020) · Movement Disorders · doi:10.1002/mds.28190 · Cited by 12
1,5-Benzodiazepin-2(3H)-ones: In Vitro Evaluation as Antiparkinsonian Agents
Ortíz de Zárate, A., Pérez-Torralba, M., Bonet Isidro, I., López, C., Claramunt, R. M., Martínez-Casanova, D., Sánchez-Vera, I., Jiménez-González, J., & Lavandera, J. L. (2021) · Antioxidants · doi:10.3390/antiox10101584 · Cited by 11
“Altered GSH concentration and increases in oxidative stress compromise cellular defenses against ROS and are associated with neurodegenerative and aging-related diseases [176,177].”
Background
Metadata
- Authors
- Garcia-Garcia, A., Zavala-Flores, L., Rodriguez-Rocha, H., & Franco, R.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2012-12-15
- Volume
- 17
- Issue
- 12
- Pages
- 1764-1784
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2030599201
- Cited by
- 83
- References
- 23
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.